COHERUS ONCOLOGY INC (CHRS:NASDAQ)
$1.82 0 (0%)
Analysed COHERUS ONCOLOGY INC (CHRS:NASDAQ) News Sources
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
16-04-2026
yahoo.com
Coherus Oncology (CHRS) Is One of the Best Penny Stocks, Here is Why – Corrected
10-04-2026
yahoo.com
Why The Coherus Oncology (CHRS) Story Is Shifting Around Growth Assumptions And Execution Risk
01-04-2026
yahoo.com
Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know
25-03-2026
yahoo.com
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
19-03-2026
yahoo.com
Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf.
14-03-2026
marketbeat.com
Coherus Oncology Inc (CHRS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
10-03-2026
yahoo.com
Coherus Oncology Q4 Earnings Call Highlights
09-03-2026
marketbeat.com
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates
09-03-2026
yahoo.com
Coherus Oncology: Q4 Earnings Snapshot
09-03-2026
yahoo.com
What is the current price of COHERUS ONCOLOGY INC (CHRS:NASDAQ)?
The current price of COHERUS ONCOLOGY INC (CHRS:NASDAQ) is $1.82.
COHERUS ONCOLOGY INC (CHRS:NASDAQ) absolute price change since previous trading day?
The absolute price change of COHERUS ONCOLOGY INC (CHRS:NASDAQ) since the previous trading day is $0.
COHERUS ONCOLOGY INC (CHRS:NASDAQ) percentage price change since previous trading day?
The percentage price change of COHERUS ONCOLOGY INC (CHRS:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for COHERUS ONCOLOGY INC (CHRS:NASDAQ)?
The most recent average sentiment score for COHERUS ONCOLOGY INC (CHRS:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for COHERUS ONCOLOGY INC (CHRS:NASDAQ)?
The most recent sentiment for COHERUS ONCOLOGY INC (CHRS:NASDAQ) is .
SEC-8K** Filing Available For COHERUS ONCOLOGY INC (CHRS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.